Quiz
L19 STIs
Este quiz tem tipos de pergunta que abrem no player de sempre.
Perguntas do quiz (16)
1Common types of sexually transmitted infections in NZ:
• [blank_start]Bacterial[blank_end] - Chlamydia trachomatis, Neisseria gonorrhoeae, Treponema pallidium
• [blank_start]Protozoal[blank_end] - Trichomonas vaginalis
• [blank_start]Viral[blank_end] – HSV, HPV, HIV- ABacterial
- BProtozoal
- CViral
2At risk populations:
• very young - infected in [blank_start]utero[blank_end] or at birth
• sexually active young adults, especially those who [blank_start]drink[blank_end]- Autero
- Bdrink alcohol
3Chlamydia trachomatis:
• non-motile [blank_start]gram –ve cocci[blank_end]
• 2 specialised forms - intracellular & extracellular. Obligate [blank_start]intracellular[blank_end] pathogen.
- Disease in Women: commonly asymptomatic [blank_start](75[blank_end]%), urethritis &/or cervicitis, purulent [blank_start]discharge[blank_end], burning [blank_start]sensation[blank_end]. If untreated an ascending infection can develop into [blank_start]pelvic inflammatory disease[blank_end] (PID) (40%). Involvement of uterus, fallopian tubes & ovaries - chronic pain (18%), infertility ([blank_start]20[blank_end]%), life threatening ectopic pregnancy (9%)
- Disease in utero/neonates: [blank_start]premature[blank_end] birth, conjunctivitis, pneumonia
- Disease in Men - asymptomatic infection ([blank_start]50[blank_end]%), urethritis - discharge, pain on urination, epididymitis - swollen, painful testicles, [blank_start]proctitis[blank_end] - (rectal infection; pain, bleeding, discharge), untreated – infertility
• Diagnosis
- direct culture not possible, [blank_start]PCR test[blank_end] is available
• Treatment
- [blank_start]contacts[blank_end] must also be treated, 1 or 7 day therapy
• Prevention: Education, [blank_start]Screening[blank_end] programmes for high risk groups- Agram –ve cocci
- Bintracellular
- C(75
- Ddischarge
- Esensation
- Fpelvic inflammatory disease
- G20
- Hpremature
- I50
- Jproctitis
- KPCR test
- Lcontacts
- Mscreening
4Gonorrhoea - "The Clap"
• Neisseria gonorrhoeae - [blank_start]gram negative diplococci[blank_end], closely related to N. meningitidis
• person to person transmission
• Infection limited to [blank_start]mucus[blank_end] membranes lined with [blank_start]columnar[blank_end] epithelium (urethra, cervix, rectum, pharynx, conjunctiva)
- Disease in Adults: may be asymptomatic (~ [blank_start]50[blank_end]% females, [blank_start]30[blank_end]% males). Inflammation, dysuria, [blank_start]discharge[blank_end] (scant/copious, mucoid/purulent)/ in on urination may be extreme. Complications - ascending infection (male - [blank_start]prostate, testicles[blank_end]: female -
[blank_start]PID[blank_end]) causing infertility - systemic spread (endocarditis, [blank_start]meningitis[blank_end]),
- Neonates: 2016 – 4 cases < 1 year of age. Ocular infection can lead to [blank_start]blindness[blank_end].
• Testing/Diagnosis: routine testing should occur for high risk individuals ([blank_start]2[blank_end] weeks post contact), self collected sampling possible. First line test: [blank_start]nucleic acid amplification[blank_end] tests. [blank_start]Culture[blank_end] for detection of new/unknown resistance mutations. Follow up test at [blank_start]3 months[blank_end].
• Treatment: many strains now [blank_start]AMR[blank_end], should also treat for [blank_start]chlamydia[blank_end].- Agram negative diplococci
- Bmucous
- Ccolumnar
- D50
- E30
- Fdischarge
- Gprostate, testicles
- HPID
- Imeningitis
- Jblindness
- K2
- Lnucleic acid amplification
- MCulture
- N3 months
- OAMR
- Pchlamydia
5Trichomonas vaginalis (TV)
• Protozoa, obligate human pathogen of [blank_start]genitourinary[blank_end] tract, twitching motility, sexually transmitted
• Common - affects [blank_start]5-10[blank_end]% men & women
• Often found with other [blank_start]STI[blank_end] pathogens
- Disease in Women: asymptomatic (>[blank_start]50[blank_end]%). Thin [blank_start]frothy yellowish green[blank_end] discharge, foul [blank_start]odour[blank_end], vulva red and [blank_start]swollen[blank_end], itching, post-coital bleeding, cervical [blank_start]haemorrhage[blank_end], abdominal pain (+/-). Complications - risk factor for other STI, [blank_start]pre-term[blank_end] delivery, very [blank_start]rarely[blank_end] infertility if have severe disease with spread to fallopian tubes.
- Disease in Men: asymptomatic, [blank_start]self-limiting[blank_end] infection, risk factor for other STI. [blank_start]Urethritis[blank_end], thin yellow-green discharge, pain on urination.
- Disease in Neonates: 2-17% of female infants born to infected mothers will develop vaginal infections, usually [blank_start]asymptomatic, self-limiting[blank_end].
- Diagnosis & Treatment: microscopy, culture - also of [blank_start]contacts[blank_end]. Treat with [blank_start]metronidazole[blank_end] – oral better cure than topical. Resistance in 4-10% of cases & no vaccine.- Agenitourinary
- B5-10
- CSTI
- D50
- Efrothy yellowish green
- Fodour
- Gswollen
- Hhaemorrhage
- Ipre-term
- Jrarely
- Kself-limiting
- LUrethritis
- Masymptomatic, self-limiting
- Ncontacts
- Ometronidazole
6T. pallidum - Syphilis.
• spiral shaped [blank_start]bacteria[blank_end], obligate human pathogen
• increases risk of [blank_start]HIV[blank_end] infection
• in pregnancy, infection can cause [blank_start]miscarriage[blank_end] and infection of the newborn
• diagnosis - direct [blank_start]microcopy[blank_end] or specific [blank_start]antibodies[blank_end] (ELISA)
• treatment - [blank_start]intramuscular[blank_end] penicillin: [blank_start]long[blank_end]-acting Bicillin (benzathine penicillin) [blank_start]1.8[blank_end]g, as short-acting formulations are [blank_start]insufficient[blank_end] for syphilis treatment.
82% of cases are [blank_start]men[blank_end] who have sexual contact with [blank_start]other men[blank_end].
Is routine to screen for it in [blank_start]antenatal[blank_end] screening.- Abacteria
- BHIV
- Cmiscarriage
- Dmicroscopy
- Eantibodies
- Fintramuscular
- Glong
- H1.8
- Iinsufficient
- Jmen
- Kother men
- Lantenatal
7Syphilis - stages of infection
• 65% men and [blank_start]50[blank_end]% of women symptomatic
• primary - painless [blank_start]ulcerative[blank_end] sore on genitals, maybe internal or external, heal [blank_start]spontaneously[blank_end] within 3-6 weeks
• secondary - skin [blank_start]rash[blank_end] with brown sores , always on [blank_start]palms[blank_end] of hands, [blank_start]soles[blank_end] of feet; mild [blank_start]fever[blank_end], aches etc. rash spontaneously resolves - sores highly [blank_start]infectious[blank_end].
• latent - no further symptoms, non-infectious
• tertiary - systemic spread and damage to [blank_start]brain, heart, eyes[blank_end]; results in mental illness, blindness or even death- A50
- Bulcerative
- Cspontaneously
- Drash
- Epalms
- Fsoles
- Gfever
- Hinfectious
- Ibrain, heart, eyes
8Genital warts are caused by [blank_start]human papillomavirus[blank_end] (HPV).
• Extremely common ~ [blank_start]75[blank_end]% of sexually active adults will have been infected
• Sexually transmissible; highly [blank_start]infectious[blank_end] when warts are present but still may be infectious when virus is [blank_start]latent[blank_end].
• HPVs that cause external warts do not generally cause [blank_start]cancer[blank_end] BUT co-infection with different HPV types is common.
• Warts can [blank_start]vary[blank_end] in size and appearance, often appear in [blank_start]clusters[blank_end]
• Women's are often [blank_start]internal[blank_end] (cervix and vagina)
• Few other symptoms; recurrent disease- Ahuman papillomavirus
- B75
- Cinfectious
- Dlatent
- Ecancer
- Fvary
- Gclusters
- Hinternal
9Genital Herpes
• Herpes simplex virus type 1 & 2 (HSV-1, HSV-2)
• Both [blank_start]oral[blank_end] (HSV-1) and [blank_start]genital[blank_end] lesions (HSV-2)
• Infection is through [blank_start]broken[blank_end] skin via contact with person having an [blank_start]outbreak[blank_end]
• Non-curable STI, virus remains latent in [blank_start]nerve endings[blank_end]
• Oral [blank_start]antivirals[blank_end] can hasten resolution of disease (~1 [blank_start]day[blank_end]), no impact on risk or severity of recurrences
- Adults - often asymptomatic, primary infection - systemic symptoms ([blank_start]fever, headache, malaise[blank_end]) + local
symptoms (pain, itching, discharge, pustular or ulcerative [blank_start]lesions[blank_end]). \Outbreaks - no symptoms or local symptoms only, outbreak frequency [blank_start]decreases[blank_end] with time. Complications - disseminated/[blank_start]systemic[blank_end] infection, CNS complications ([blank_start]meningitis[blank_end])
- Neonates - infected at delivery, greater risk if [blank_start]primary[blank_end] infection (50%, < 5% for outbreak). Mortality rate of [blank_start]65[blank_end]% from disseminated disease.- Aoral
- Bgenital
- Cbroken
- Doutbreak
- Enerve endings
- Fantivirals
- Gday
- Hfever, headache, malaise
- Ilesions
- Jdecreases
- Ksystemic
- Lmeningitis
- Mprimary
- N65
10HIV
• Human immunodeficiency virus
• Cellular target of HIV are [blank_start]CD4+ cells[blank_end] T cells
• gp120 binds to CD4 causing [blank_start]conformational[blank_end] changes to take place; allows binding of gp120 to [blank_start]coreceptors[blank_end]
(CCR5 or CXCR4)
• gp41 can [blank_start]penetrate[blank_end] cell surface
Epidemiology:
• World: 2016 – 36.7 million people living with HIV & 18.2 on accessing therapy, 2 million new infections & 1.2 million deaths
• NZ rate in low. Biggest [blank_start]decline[blank_end] in men who have sexual contact with men. [blank_start]No[blank_end] cases of perinatally HIV
since 2007.- ACD4+ cells
- Bconformational
- Ccoreceptors
- Dpenetrate
- Edecline
- FNo
11Stages of HIV lifecycle targeted by drugs:
1. Attachment & fusion - [blank_start]block[blank_end] attachment or fusion
2. Reverse transcription - nucleoside & non nucleoside [blank_start]RT inhibitors[blank_end]
3. Integration – viral [blank_start]integrase[blank_end] inhibitors
4. Processing of viral proteins - [blank_start]HIV protease[blank_end] inhibitors- Ablock
- BRT inhibitors
- Cintegrase
- DHIV protease
12NZ guidelines are: HIV testing of all pregnant women.
- AVerdadeiro
- BFalso
13HIV Pathophysiology
1.Primary Infection
• Infection initially establishes in [blank_start]lymphoid[blank_end] tissue - fever, malaise, headache, lymphadenopathy
• active viral [blank_start]replication[blank_end] - 109 new virions produced each day, t1/2 of 1.6 days for cells
• immune response kicks in - cytotoxic [blank_start]CD8[blank_end] T cell response + antibody (seroconversion)
• infected cells are eliminated, virus titres [blank_start]decrease[blank_end]
2. Latent Disease
• longest lasting stage of disease ([blank_start]2-3[blank_end] years for rapid progressors, up to [blank_start]10[blank_end] years for long term non progressors)
• low level chronic [blank_start]immune[blank_end] activation & persistent viral replication, immune response ongoing
• patients are [blank_start]asymptomatic[blank_end]
• CD4 cells gradually [blank_start]decline[blank_end] due to direct viral killing and CD8 killing
• new CD4 cells can not be [blank_start]generated[blank_end], CD8 response drops off due to viral [blank_start]mutation[blank_end]
3. Advanced Disease
• characterised by either:
- [blank_start]AIDS[blank_end]-defining illness (atypical infection or cancer eg Kaposi’s sarcoma)
- decline in CD4 T cell counts below [blank_start]200 cells/mL[blank_end]
• viral titres [blank_start]increase[blank_end], disintegration of lymphoid [blank_start]organs[blank_end], T & B cell responses decline, death from [blank_start]infection[blank_end] or cancer- Alymphoid
- Breplication
- CCD8
- Ddecrease
- E2-3
- F10
- Gimmune
- Hasymptomatic
- Idecline
- Jgenerated
- Kmutation
- LAIDS
- M200 cells/mL
- Nincrease
- Oorgans
- Pinfection
14Managing HIV patients
• [blank_start]CD4 +/- viral load[blank_end] monitoring
• [blank_start]Screening[blank_end] for diseases more common or more aggressive in patients with HIV
• [blank_start]Immunisation[blank_end]
If necessary/when required:
• [blank_start]Anti-retroviral[blank_end] Therapy (ART) – NZ 2018 - 2463 people on ART
• [blank_start]Prophylaxis[blank_end] against opportunistic infections
• Treat infections/malignancies
Drugs:
- Current US guidelines - An antiretroviral regimen generally consists of [blank_start]two[blank_end] nucleoside reverse transcriptase inhibitors ([blank_start]NRTIs[blank_end]), in combination with a third [blank_start]active antiretroviral[blank_end] drug from one of three drug classes:
1. an integrase strand transfer inhibitor,
1. a non-nucleoside reverse transcriptase inhibitor (NNRTI), or
3. a protease inhibitor (PI) with a pharmacokinetic enhancer (cobicistat or ritonavir).- ACD4 +/- viral load
- BScreening
- CImmunisation
- DAnti-retroviral
- EProphylaxis
- Ftwo
- GNRTIs
- Hactive antiretroviral
15ART
• Simple regimen, low [blank_start]pill burden[blank_end]
• Adherence is [blank_start]critical[blank_end]
• Low [blank_start]side effect[blank_end] profile – interactions [blank_start]common[blank_end] - Many ARVs are metabolised by cytochrome [blank_start]P450[blank_end], & the CYP3A4 inhibitors (eg ritonavir) are give in ‘boosted’ regimens.
• High threshold for [blank_start]resistance[blank_end]
• Cure – get rid of latent virus?, transplant with CCR5-ve immune system- Apill burden
- Bcritical
- Cside effect
- Dcommon
- EP450
- Fresistance
16HIV/AIDS Prevention
• Education and behavior modification
• PrEP
• [blank_start]Drug abuse[blank_end] treatment (e.g. methadone)
• Condoms, clean [blank_start]syringes[blank_end]
• Treatment of other [blank_start]sexually transmitted[blank_end] diseases
• Interruption of [blank_start]transmission[blank_end] from mother to child
• Vaccine- ADrug abuse
- Bsyringes
- Csexually transmitted
- Dtransmission
Informações
- Descrição
- O usuário eliminou as informações de disciplina Quiz sobre L19 STIs, criado por Usuário eliminado em 02-10-2019.
- Autor
- Usuário eliminado
- Idioma
- English
- Visualizações
- 107
- Histórico
- Criado em 2 out 2019 · atualizado em 2 out 2019
- Etiquetas
- Avaliação
- Ainda sem avaliações Avalie este quiz